Company page
Apex Biotechnology Corp.
Apex Biotechnology Corp. is a publicly traded company on the Taiwan stock market under the ticker 1733. The company has a market capitalization of approximately 97.6 million USD. Apex Biotechnology focuses on the development and production of innovative medical technologies and solutions.

- Ticker
- 1733
- Market cap
- $91.9M
- Sector
- Health Technology
- Industry
- Biotechnology